v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Jun. 30, 2024
Operating activities:      
Net loss $ (134,765) $ (199,993) $ (6,105)
Reconciliation of net loss to net cash provided by (used in) operating activities, net of acquisitions:      
Goodwill and intangible impairment 45,154 143,823 19,762
Depreciation and amortization 53,617 53,618 53,752
Amortization of deferred financing costs 1,412 866 724
Deferred income taxes (693) (12,723) (11,732)
Bad debt expense 223 674 251
Stock-based compensation 11,256 11,891 10,688
Other non-cash items 776 2,013 310
Changes in operating items, net of acquisitions:      
Trade receivables 3,553 (4,284) 2,143
Inventories 24,344 756 14,572
Prepaid and other 11,686 (5,682) 2,913
Accounts payable and accrued expenses (199) (16,997) 6,404
Other assets and other liabilities 1,944 (325) 1,317
Net cash provided by (used in) operating activities 18,308 (26,363) 94,999
Investing activities:      
Acquisitions, net of cash acquired 0 (3,000) (3,672)
Capital expenditures (31,280) (41,463) (38,632)
Net cash used in investing activities (31,280) (44,463) (42,304)
Financing activities:      
Acquisition of treasury stock (1,164) (10,175) (10,394)
Proceeds from exercise of employee stock options 0 281 329
Proceeds from bank borrowings 175,000 110,000 82,000
Repayment of bank borrowings (196,000) (140,000) (92,000)
Debt issuance costs 0 (2,215) 0
Net cash used in financing activities (22,164) (42,109) (20,065)
Net change in cash and cash equivalents (35,136) (112,935) 32,630
Cash and cash equivalents:      
Beginning of year 46,502 159,437 126,807
End of year $ 11,366 $ 46,502 $ 159,437